Sean D McGarry1, Sarah L Hurrell2, Kenneth A Iczkowski3, Amy Kaczmarowski2, Anjishnu Banerjee4, Tucker Keuter4, Kenneth Jacobsohn5, William Hall6, Marja Nevalainen3, Mark Hohenwalter2, William See5, Andrew Nencka2, and Peter LaViolette2
1Biophysics, Medical College of Wisconsin, Wawautosa, WI, United States, 2Radiology, Medical College of Wisconsin, Wawautosa, WI, United States, 3Pathology, Medical College of Wisconsin, Wawautosa, WI, United States, 4Biostatistics, Medical College of Wisconsin, Wawautosa, WI, United States, 5Urologic Surgery, Medical College of Wisconsin, Wawautosa, WI, United States, 6Radiation Oncology, Medical College of Wisconsin, Wawautosa, WI, United States
Synopsis
We present a machine learning technique for
mapping prostate cancer cellular features into MRI space. 39 patients were
prospectively recruited for imaging prior to prostaectomy. Tissue was aligned
with the MRI using a non-linear control point warping technique. Pathologist annotations
were likewise transformed into MRI space. A partial least squares regression
(PLS) algorithm was trained on two sets of 10 patients and applied to 19 test patients,
using MRI values as the input to predict epithelial and lumen density. The output
maps are new interpretable image contrasts predictive of prostate cancer
presence.
Introduction
One
in seven men will be diagnosed with prostate cancer, though not all cases are
clinically significant[1]. Differentiation of
indolent from aggressive disease is a major focus of ongoing radiological
studies. Rad-path correlation is the integration of radiology and pathology,
where diagnostic information from tissue is aligned with medical imaging to
validate imaging technology[2,3]. This study applies machine learning
to two training datasets of quantitatively characterized whole mount prostate
histology aligned to noninvasive imaging to test the hypothesis that predictive
maps of pathological features indicative of high-grade cancer can be generated
using non-invasive imaging alone.[4,5]Methods
We
prospectively recruited thirty-nine patients undergoing prostatectomy for this
institutional review board (IRB) approved study. Patients underwent MP-MRI
prior to prostatectomy on a 3T MRI scanner (General Electric, Waukesha, WI)
using an endorectal coil. MP-MRI included field-of-view (FOV) optimized and
constrained undistorted single shot (FOCUS) diffusion weighted imaging (DWI)
with ten b-values (b=0, 10, 25, 50, 80, 100, 200, 500, 1000, and 2000), dynamic
contrast enhanced (DCE) imaging, and T2-weighted imaging. T2 weighted images
were intensity normalized and apparent diffusion coefficient maps were
calculated. The DCE data was used to calculate the percent change in signal
intensity before and after contrast injection. All images were aligned to the
T2 weighted image.
Robotic
prostatectomy was performed within 2 weeks of imaging. Prostate samples were
sliced using a custom 3D printed slicing jigs matching the slice profile of the
T2 weighted image. Whole mount samples were hematoxylin and eosin stained,
digitized, and annotated by a board certified pathologist (Figure 1). A total
of 210 slides were included in this study.
Lumen and epithelium density were automatically
segmented from the histology using a custom algorithm written in MATLAB. The
algorithm was validated by comparing manual to automatic segmentation on 18
samples. Slides were aligned with the T2 weighted image using a non-linear
control point warping technique.[6] Lumen and epithelium density and
the expert annotation were likewise transformed into MRI space.
To
determine the optimal number of patients required to train the algorithm, a
learning curve was generated using a PLS algorithm trained on 150 random
permutations of patients incrementing from 1 to 29 patients. Slides were
stratified such that all slides from a single patient were in the same cohort.
Three cohorts were generated, with tumor burden balanced across all cohorts.
A
PLS algorithm was trained on two independent training sets (cohorts 1 and 2)
and applied to Test cohort 3. The input vector consisted of MRI values and the
target variable was lumen and epithelium density. The algorithm was trained
lesion-wise. Each model was then applied to the MRI data from the Test cohort 3
to generate predictive cytological topography (PiCT) maps of epithelium and
lumen density. Mean lesion values were compared between high grade, low grade,
and healthy tissue using an ANOVA. An ROC analysis was performed lesion-wise on
the test set.
Results
The segmentation accuracy
validation (automatic vs. manual) revealed R=0.99 and R=0.72 (p<0.001) for
lumen and epithelium respectively. The learning curve stabilized at 10 patients
with a minimized root mean square error of 0.14, thus the size of the two
independent training cohorts was set to 10, leaving 19 for test cohort 3.
Figure
3 shows PiCT maps from 4 representative patients, where regions of increased
epithelium density and decreased lumen density correspond with regions of high-grade
cancer. All ANOVA comparisons were significant (p<0.05) and the resulting
trends matched the trends from the histology (Figure 4). The ROC analysis performed
on test cohort 3 to quantify differentiation of high grade tumors from other
tissues yielded an
AUC of 0.74 and 0.82 for Model 1 epithelium and lumen density respectively, and
0.82 when combined. Model 2 had an AUC of 0.70 and 0.80, for epithelium and
lumen density respectively and a AUC of 0.80 for a combination of the two
(Figure 5).Discussion
We
present a radio-pathomics approach to mapping the predicted histo-pathological
features using non-invasive imaging alone. This voxel-wise approach effectively
generates new image contrasts for radiologist interpretation, which can
potentially increase diagnostic confidence and guide biopsy and radiation
treatment. Acknowledgements
Advancing a Healthier Wisconsin and the State of Wisconsin Tax Check off Program for Prostate Cancer Research. National Center for Advancing Translational Sciences, NIH UL1TR001436 and TL1TR001437, and RO1CA218144References
1. Siegel
RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30.
2. Nguyen HS, Milbach N, Hurrell SL, et al. Progressing Bevacizumab-Induced
Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by
Viable Tumor and Decreased Overall Survival in Patients with Recurrent
Glioblastoma. AJNR Am J Neuroradiol. 2016;37(12):2201-2208.
3. Pokorny MR, de Rooij M, Duncan E, et al. Prospective study of diagnostic
accuracy comparing prostate cancer detection by transrectal ultrasound-guided
biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy
in men without previous prostate biopsies. Eur
Urol. 2014;66(1):22-29.
4. Kwak JT, Sankineni S, Xu S, et al. Correlation of magnetic resonance
imaging with digital histopathology in prostate. Int J Comput Assist Radiol Surg. 2016;11(4):657-666.
5. Fehr D, Veeraraghavan H, Wibmer A, et al. Automatic classification of
prostate cancer Gleason scores from multiparametric magnetic resonance images. Proc Natl Acad Sci U S A. 2015;112(46):E6265-6273.
6. Nguyen HS, Milbach N, Hurrell SL, et al. Progressing Bevacizumab-Induced
Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by
Viable Tumor and Decreased Overall Survival in Patients with Recurrent
Glioblastoma. AJNR Am J Neuroradiol. 2016.